CLBS Annual Total Liabilities
$5.01 M
+$1.25 M+33.19%
31 December 2021
Summary:
As of January 30, 2025, CLBS annual total liabilities is $5.01 million, with the most recent change of +$1.25 million (+33.19%) on December 31, 2021. During the last 3 years, it has fallen by -$2.12 million (-29.72%).CLBS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Quarterly Total Liabilities
$6.76 M
+$3.02 M+80.70%
01 September 2022
Summary:
As of January 30, 2025, CLBS quarterly total liabilities is $6.76 million, with the most recent change of +$3.02 million (+80.70%) on September 1, 2022. Over the past year, it has increased by +$2.63 million (+63.83%).CLBS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.2% | +63.8% |
| 3 y3 years | -29.7% | +1.0% |
| 5 y5 years | -62.0% | -53.6% |
CLBS Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -93.3% | -92.2% |
Caladrius Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $6.76 M(+80.7%) |
| June 2022 | - | $3.74 M(+16.1%) |
| Mar 2022 | - | $3.22 M(-35.7%) |
| Dec 2021 | $5.01 M(+33.2%) | $5.01 M(+21.4%) |
| Sept 2021 | - | $4.13 M(+4.8%) |
| June 2021 | - | $3.94 M(-14.3%) |
| Mar 2021 | - | $4.59 M(+22.2%) |
| Dec 2020 | $3.76 M(-43.0%) | $3.76 M(-17.0%) |
| Sept 2020 | - | $4.53 M(+15.5%) |
| June 2020 | - | $3.92 M(-23.9%) |
| Mar 2020 | - | $5.16 M(-21.9%) |
| Dec 2019 | $6.60 M(-7.4%) | $6.60 M(-1.3%) |
| Sept 2019 | - | $6.69 M(-0.6%) |
| June 2019 | - | $6.73 M(-1.5%) |
| Mar 2019 | - | $6.83 M(-4.2%) |
| Dec 2018 | $7.13 M(-46.0%) | $7.13 M(+1.2%) |
| Sept 2018 | - | $7.04 M(-18.3%) |
| June 2018 | - | $8.63 M(-24.3%) |
| Mar 2018 | - | $11.40 M(-13.5%) |
| Dec 2017 | $13.19 M(-73.3%) | $13.19 M(-9.5%) |
| Sept 2017 | - | $14.57 M(-20.0%) |
| June 2017 | - | $18.21 M(-63.9%) |
| Mar 2017 | - | $50.50 M(+2.1%) |
| Dec 2016 | $49.45 M(+45.8%) | $49.45 M(+4.6%) |
| Sept 2016 | - | $47.29 M(-7.4%) |
| June 2016 | - | $51.08 M(+2.1%) |
| Mar 2016 | - | $50.00 M(+47.4%) |
| Dec 2015 | $33.92 M(-50.3%) | $33.92 M(-47.6%) |
| Sept 2015 | - | $64.71 M(+3.2%) |
| June 2015 | - | $62.67 M(-9.0%) |
| Mar 2015 | - | $68.85 M(+0.9%) |
| Dec 2014 | $68.20 M(+145.4%) | $68.20 M(-1.6%) |
| Sept 2014 | - | $69.28 M(+23.5%) |
| June 2014 | - | $56.10 M(+105.3%) |
| Mar 2014 | - | $27.33 M(-1.7%) |
| Dec 2013 | $27.79 M(+28.7%) | $27.79 M(+22.7%) |
| Sept 2013 | - | $22.65 M(+9.9%) |
| June 2013 | - | $20.62 M(-1.3%) |
| Mar 2013 | - | $20.89 M(-3.2%) |
| Dec 2012 | $21.59 M(-71.3%) | $21.59 M(-71.3%) |
| Sept 2012 | - | $75.10 M(-12.8%) |
| June 2012 | - | $86.17 M(+0.8%) |
| Mar 2012 | - | $85.51 M(+13.7%) |
| Dec 2011 | $75.20 M(+33.0%) | $75.20 M(+11.0%) |
| Sept 2011 | - | $67.77 M(-15.6%) |
| June 2011 | - | $80.26 M(+0.9%) |
| Mar 2011 | - | $79.54 M(+40.7%) |
| Dec 2010 | $56.54 M | $56.54 M(+70.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $33.26 M(-14.8%) |
| June 2010 | - | $39.06 M(-31.2%) |
| Mar 2010 | - | $56.74 M(+6.6%) |
| Dec 2009 | $53.24 M(+5439.9%) | $53.24 M(+411.1%) |
| Sept 2009 | - | $10.42 M(+20.7%) |
| June 2009 | - | $8.63 M(+230.0%) |
| Mar 2009 | - | $2.62 M(+172.1%) |
| Dec 2008 | $961.10 K(+109.4%) | $961.10 K(+109.8%) |
| Sept 2008 | - | $458.10 K(+55.1%) |
| June 2008 | - | $295.40 K(-26.4%) |
| Mar 2008 | - | $401.40 K(-12.5%) |
| Dec 2007 | $459.00 K(-49.2%) | $459.00 K(+21.1%) |
| Sept 2007 | - | $379.00 K(-53.3%) |
| June 2007 | - | $812.20 K(+46.9%) |
| Mar 2007 | - | $553.00 K(-38.8%) |
| Dec 2006 | $902.90 K(-63.3%) | $902.90 K(+38.2%) |
| Sept 2006 | - | $653.40 K(-76.8%) |
| June 2006 | - | $2.81 M(+47.1%) |
| Mar 2006 | - | $1.91 M(-22.3%) |
| Dec 2005 | $2.46 M(+21.1%) | $2.46 M(-4.9%) |
| Sept 2005 | - | $2.59 M(+10.1%) |
| June 2005 | - | $2.35 M(+9.8%) |
| Mar 2005 | - | $2.14 M(+5.4%) |
| Dec 2004 | $2.03 M(+11.9%) | $2.03 M(-7.4%) |
| Sept 2004 | - | $2.19 M(+10.9%) |
| June 2004 | - | $1.98 M(+0.8%) |
| Mar 2004 | - | $1.96 M(+8.2%) |
| Dec 2003 | $1.81 M(-9.6%) | $1.81 M(-0.6%) |
| Sept 2003 | - | $1.82 M(-23.1%) |
| June 2003 | - | $2.37 M(+11.1%) |
| Mar 2003 | - | $2.14 M(+6.5%) |
| Dec 2002 | $2.01 M(+37.2%) | $2.01 M(+3.5%) |
| Sept 2002 | - | $1.94 M(+15.7%) |
| June 2002 | - | $1.68 M(+10.0%) |
| Mar 2002 | - | $1.52 M(+4.3%) |
| Dec 2001 | $1.46 M(+11.9%) | $1.46 M(+1.5%) |
| Sept 2001 | - | $1.44 M(+3.2%) |
| June 2001 | - | $1.40 M(+5.2%) |
| Mar 2001 | - | $1.33 M(+1.5%) |
| Dec 2000 | $1.31 M(+4.7%) | $1.31 M(+0.4%) |
| Sept 2000 | - | $1.30 M(+13.1%) |
| June 2000 | - | $1.15 M(+17.5%) |
| Mar 2000 | - | $980.00 K |
| Dec 1999 | $1.25 M(+2.9%) | - |
| Dec 1998 | $1.21 M(+5.2%) | - |
| Mar 1998 | $1.15 M(+73.1%) | - |
| Mar 1997 | $666.60 K(+46.4%) | - |
| Mar 1996 | $455.30 K | - |
FAQ
- What is Caladrius Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Caladrius Biosciences?
- What is Caladrius Biosciences annual total liabilities year-on-year change?
- What is Caladrius Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly total liabilities year-on-year change?
What is Caladrius Biosciences annual total liabilities?
The current annual total liabilities of CLBS is $5.01 M
What is the all time high annual total liabilities for Caladrius Biosciences?
Caladrius Biosciences all-time high annual total liabilities is $75.20 M
What is Caladrius Biosciences annual total liabilities year-on-year change?
Over the past year, CLBS annual total liabilities has changed by +$1.25 M (+33.19%)
What is Caladrius Biosciences quarterly total liabilities?
The current quarterly total liabilities of CLBS is $6.76 M
What is the all time high quarterly total liabilities for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly total liabilities is $86.17 M
What is Caladrius Biosciences quarterly total liabilities year-on-year change?
Over the past year, CLBS quarterly total liabilities has changed by +$2.63 M (+63.83%)